BTK

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA001198

Antibody HPA002028

Antibody CAB016689

Tissue

Antibody staining

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

Malignant lymphomas displayed strong cytoplasmic immunoreactivity. Malignant gliomas were weakly stained. Remaining malignant tissues were in general negative. Malignant lymphomas and few malignant gliomas displayed strong cytoplasmic immunoreactivity. Remaining malignant tissues were generally weakly stained or negative.Most non-Hodgkin's lymphomas and a few papillary thyroid cancers showed strong cytoplasmic positivity. Malignant gliomas were weakly stained. Remaining malignant tissues were generally negative.

Validation

Supportive: Two (or more) antibodies yielding similar staining patterns which are consistent with available gene/protein characterization data
Supportive: Two (or more) antibodies yielding similar staining patterns which are consistent with available gene/protein characterization data
Supportive: Two (or more) antibodies yielding similar staining patterns which are consistent with available gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected